2022 CPI-Based Price-Adjustment Factors for Patented Drug Products

The following table provides the CPI-Based Price-Adjustment factors for 2022. These factors were based on the actual rate of CPI inflation of 2.3% in 2018, 2.0% in 2019, and 0.7% in 2020.

CPI-Based Price-Adjustment factors for 2022

Benchmark Year

2019

2020

2021

Price-Adjustment Factor

1.050

1.027

1.007

Based on these factors, one can derive: (1) a maximum allowable cumulative price increase of 5.0% between 2019 and 2022 for patented medicines with Canadian sales in 2019; (2) a maximum allowable cumulative price increase of 2.7% between 2020 and 2022 for patented medicines with Canadian sales in 2020; and (3) a maximum allowable cumulative price increase of 0.7% between 2021 and 2022 for patented medicines with Canadian sales in 2021.

The year-over-year price increase cap for the 12-month period ending December 2022 is 1.1% (=1.5 x Actual Inflation in 2020).

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: